Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Triple-blind, Placebo Controlled Parallel Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults

NCT07692633 is registered in ClinicalTrials.gov with Reus Research as lead sponsor.

NCT NCT07692633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07692633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Triple-blind, Placebo Controlled Parallel Clinical Trial to Assess the Absorption, Safety, and Efficacy of an Oral Nicotinamide Adenine Dinucleotide (NAD+) Supplement in Healthy Adults
Lead sponsor
Reus Research
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
March 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nad+ bioavailability, nad+ efficacy, nad+ safety